Terms: = Sarcomas AND CCND3, P30281, 896, ENSG00000112576
34 results:
1. Intratumoral and peritumoral MRI-based radiomics prediction of histopathological grade in soft tissue sarcomas: a two-center study.
Zhang L; Yang Y; Wang T; Chen X; Tang M; Deng J; Cai Z; Cui W
Cancer Imaging; 2023 Oct; 23(1):103. PubMed ID: 37885031
[TBL] [Abstract] [Full Text] [Related]
2. Clinical Targeted Next-Generation Panel Sequencing Reveals
Marinoff AE; Spurr LF; Fong C; Li YY; Forrest SJ; Ward A; Doan D; Corson L; Mauguen A; Pinto N; Maese L; Colace S; Macy ME; Kim A; Sabnis AJ; Applebaum MA; Laetsch TW; Glade-Bender J; Weiser DA; Anderson M; Crompton BD; Meyers P; Zehir A; MacConaill L; Lindeman N; Nowak JA; Ladanyi M; Church AJ; Cherniack AD; Shukla N; Janeway KA
JCO Precis Oncol; 2023 Mar; 7():e2200334. PubMed ID: 36996377
[TBL] [Abstract] [Full Text] [Related]
3. [Mutation characteristics of osteosarcoma: a single center study of 64 cases using next-generation sequencing].
Gao DL; Dong RF; Liu WF; Gong LH; Xu HR; Niu XH; Ding Y
Zhonghua Bing Li Xue Za Zhi; 2023 Apr; 52(4):370-375. PubMed ID: 36973198
[No Abstract] [Full Text] [Related]
4. A deep belief network-based clinical decision system for patients with osteosarcoma.
Li W; Dong Y; Liu W; Tang Z; Sun C; Lowe S; Chen S; Bentley R; Zhou Q; Xu C; Li W; Wang B; Wang H; Dong S; Hu Z; Liu Q; Cai X; Feng X; Zhao W; Yin C
Front Immunol; 2022; 13():1003347. PubMed ID: 36466868
[TBL] [Abstract] [Full Text] [Related]
5. Losing CD45 and various B-cell markers in a case of MYC-driven pediatric high-grade B-cell lymphoma, not otherwise specified that transformed from Burkitt's lymphoma during rituximab-containing treatments: a case report.
Xue X; Fu L; Qiu T; Cao Z; Wang X; Rao W; Luo Y; He L; Feng X
Virchows Arch; 2023 Jul; 483(1):111-116. PubMed ID: 36383247
[TBL] [Abstract] [Full Text] [Related]
6. Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma.
Thomas N; Dreval K; Gerhard DS; Hilton LK; Abramson JS; Ambinder RF; Barta S; Bartlett NL; Bethony J; Bhatia K; Bowen J; Bryan AC; Cesarman E; Casper C; Chadburn A; Cruz M; Dittmer DP; Dyer MA; Farinha P; Gastier-Foster JM; Gerrie AS; Grande BM; Greiner T; Griner NB; Gross TG; Harris NL; Irvin JD; Jaffe ES; Henry D; Huppi R; Leal FE; Lee MS; Martin JP; Martin MR; Mbulaiteye SM; Mitsuyasu R; Morris V; Mullighan CG; Mungall AJ; Mungall K; Mutyaba I; Nokta M; Namirembe C; Noy A; Ogwang MD; Omoding A; Orem J; Ott G; Petrello H; Pittaluga S; Phelan JD; Ramos JC; Ratner L; Reynolds SJ; Rubinstein PG; Sissolak G; Slack G; Soudi S; Swerdlow SH; Traverse-Glehen A; Wilson WH; Wong J; Yarchoan R; ZenKlusen JC; Marra MA; Staudt LM; Scott DW; Morin RD
Blood; 2023 Feb; 141(8):904-916. PubMed ID: 36201743
[TBL] [Abstract] [Full Text] [Related]
7. A rapidly growing cutaneous malignant glomus tumor with a ccnd3 mutation.
Kitz R; Leung O; Royer M
J Cutan Pathol; 2023 Feb; 50(2):113-117. PubMed ID: 36059094
[TBL] [Abstract] [Full Text] [Related]
8. Predicting distant metastases in soft-tissue sarcomas from PET-CT scans using constrained hierarchical multi-modality feature learning.
Peng Y; Bi L; Kumar A; Fulham M; Feng D; Kim J
Phys Med Biol; 2021 Dec; 66(24):. PubMed ID: 34818637
[No Abstract] [Full Text] [Related]
9. Embryonal rhabdomyosarcoma completely resected at diagnosis: The European paediatric Soft tissue sarcoma Study Group RMS2005 experience.
Bergeron C; Jenney M; De Corti F; Gallego S; Merks H; Glosli H; Ferrari A; Ranchère-Vince D; De Salvo GL; Zanetti I; Chisholm J; Minard-Colin V; Rogers T; Bisogno G;
Eur J Cancer; 2021 Mar; 146():21-29. PubMed ID: 33567392
[TBL] [Abstract] [Full Text] [Related]
10. Cyclin Pathway Genomic Alterations Across 190,247 Solid Tumors: Leveraging Large-Scale Data to Inform Therapeutic Directions.
Jardim DL; Millis SZ; Ross JS; Woo MS; Ali SM; Kurzrock R
Oncologist; 2021 Jan; 26(1):e78-e89. PubMed ID: 32885893
[TBL] [Abstract] [Full Text] [Related]
11. Differential expression of AURKA/PLK4 in quiescence and senescence of osteosarcoma U2OS cells.
Xie XL; Zhu HX; Li YM; Chen DT; Fan TY
Cell Cycle; 2020 Apr; 19(8):884-894. PubMed ID: 32200684
[TBL] [Abstract] [Full Text] [Related]
12. Incidence, treatment and outcome of abdominal metastases in extremity soft tissue sarcoma: Results from a multi-centre study.
Smolle MA; Schaffler A; Leithner A; Van Praag VM; Bergovec M; Szkandera J; Liegl-Atzwanger B; Niethard M; Tunn PU; Van De Sande M; Andreou D
J Surg Oncol; 2020 Mar; 121(4):605-611. PubMed ID: 32003475
[TBL] [Abstract] [Full Text] [Related]
13. Uterine Corpus Malignancies in Appalachia Kentucky: Incidence, Survival, and Related Health Disparities.
Johnson MS; Tucker TC; Chen Q; Huang B; DeSimone CP; Miller RW; Baldwin LA; Fredericks TI; Burgess BT; Ueland FR
South Med J; 2020 Jan; 113(1):29-36. PubMed ID: 31897496
[TBL] [Abstract] [Full Text] [Related]
14. RUNX2 (6p21.1) amplification in osteosarcoma.
Gupta S; Ito T; Alex D; Vanderbilt CM; Chang JC; Islamdoust N; Zhang Y; Nafa K; Healey J; Ladanyi M; Hameed MR
Hum Pathol; 2019 Dec; 94():23-28. PubMed ID: 31669178
[TBL] [Abstract] [Full Text] [Related]
15. Targeted muscle reinnervation in oncologic amputees: Early experience of a novel institutional protocol.
Alexander JH; Jordan SW; West JM; Compston A; Fugitt J; Bowen JB; Dumanian GA; Pollock R; Mayerson JL; Scharschmidt TJ; Valerio IL
J Surg Oncol; 2019 Sep; 120(3):348-358. PubMed ID: 31197851
[TBL] [Abstract] [Full Text] [Related]
16. Rhabdomyosarcoma disease spread evaluation on CT scans: Association with primary tumor size and Ki-67 proliferation marker.
Soffer S; Amitai MM; Shimon O; Ohana O; Rozendorn N; Barshack I; Weitzen R; Klang E
Clin Imaging; 2019; 56():41-46. PubMed ID: 30875523
[TBL] [Abstract] [Full Text] [Related]
17. Crizotinib achieves long-lasting disease control in advanced papillary renal-cell carcinoma type 1 patients with MET mutations or amplification. EORTC 90101 CREATE trial.
Schöffski P; Wozniak A; Escudier B; Rutkowski P; Anthoney A; Bauer S; Sufliarsky J; van Herpen C; Lindner LH; Grünwald V; Zakotnik B; Lerut E; Debiec-Rychter M; Marréaud S; Lia M; Raveloarivahy T; Collette S; Albiges L
Eur J Cancer; 2017 Dec; 87():147-163. PubMed ID: 29149761
[TBL] [Abstract] [Full Text] [Related]
18. Volume fractions of DCE-MRI parameter as early predictor of histologic response in soft tissue sarcoma: A feasibility study.
Xia W; Yan Z; Gao X
Eur J Radiol; 2017 Oct; 95():228-235. PubMed ID: 28987672
[TBL] [Abstract] [Full Text] [Related]
19. Experiences with surgically treated primary or secondary hepatic sarcoma.
Fahrner R; Dennler SGC; Dondorf F; Ardelt M; Rauchfuss F; Settmacher U
Langenbecks Arch Surg; 2017 Jun; 402(4):585-590. PubMed ID: 28110373
[TBL] [Abstract] [Full Text] [Related]
20. Sorafenib in patients with locally advanced and metastatic chordomas: a phase II trial of the French Sarcoma Group (GSF/GETO).
Bompas E; Le Cesne A; Tresch-Bruneel E; Lebellec L; Laurence V; Collard O; Saada-Bouzid E; Isambert N; Blay JY; Amela EY; Salas S; Chevreau C; Bertucci F; Italiano A; Clisant S; Penel N
Ann Oncol; 2015 Oct; 26(10):2168-73. PubMed ID: 26202596
[TBL] [Abstract] [Full Text] [Related]
[Next]
